Vaginal misoprostol for post-partum haemorrhage prevention;Misoprostol vaginal para la prevención de la hemorragia posparto

Ginecologia y Obstetricia de Mexico

Volumn 70, Issue NOV., 2002, Pages 572-575

  Quiroga Diaz R ^a   Esparza Arechiga, M ^a   Batiza Resendiz V ^a   Coronado Lopez O ^a   Hernandez Ayup S ^a   Martinez Cuervo J ^a  

^a Hospital de Ginecología Y Obstetricia de Monterrey   (Mexico)

Author keywords

Haemorrhage; Misoprostol; Post partum

Indexed keywords

ERGOTAMINE; MISOPROSTOL; OXYTOCIN;

ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CONTROLLED STUDY; DIARRHEA; DRUG COST; DYSTOCIA; FEMALE; HEADACHE; HIGH RISK POPULATION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; POSTPARTUM HEMORRHAGE; VOMITING;

EID: 0036872841     PISSN: 03009041     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ratnam SS, Viegas OAC, Sing K. Magnitude and causes of maternal mortality as a basis for its prevention. En: Kassel E, Awan A.K.eds Maternal and child care in developing countries. Zurich. Switzerland: Ott Publishers. 1989: 80-90.
2. Turmen T. Safe motherhood: A global problem. En: Report from a symposium on the prevention and management of anaemia in pregnancy and postpartum hemorrhage. World Health Organization. Zurich, 1996:1-13.
3. Arias F. Guía práctica para el embarazo y parto de alto riesgo, segunda edición 1995; 21: 446-64.
4. Goodman and Gilman. Farmacologia 9a. edicion. Autacoides derivados de lípidos 1997; 26: 643-53.
5. O'Brien P, El Refaey, Gordon A, Geary M, Rodeck Ch. Rectally administered for the treatment of postpartum hemorrhage unresponsive to oxytocin and Ergometrine: A descriptive study. Obstet Gynecol 1998; 92: 212-4.
6. Bamigboye AA, Hofmeyr GJ, Merrell DA. Coronation Hospital Johannesburg, South Africa. Rectal misoprostol in the prevention of postpartum hemorrhage. Am J Obstet Gynecol 1998; 179: 1043-6.
7. El Refaey H, O'Brien P, Morafa W, Walder J, Rodeck C. University College Hospital, London UK. Use of oral misoprostol in the prevention of postpartum hemorrhage, Br J Obstet Gynecol 1997; 104: 336-9.
8. Chalmers I, Enkin M, Keirse MJNC, editors.Effective care in Pregnancy and childbirth, Oxford: Oxford University Press. 1989: 1145-69.
9. Prendiville WL, Harding JE, Elbourne DR, Stirrat GM. The bristol third stage trial: active versus physiological management of third stage of labour. BMJ 1988; 297: 1295-300.
10. Morgan BM, Aulakh JM, Barker JP, Reginald PW, Goroszeniuk T. Anaesthetic morbility following caesarean section under epidural or general anaesthesia. Lancet 1984; 1: 328-30.
11. El Refaey H, Rajasekar D, Abdalla M, Templeton A. Oral vs. vaginal misoprostol with Ru 486 for first trimester abortion N Engl J Med 1995; 332: 983-7.
12. Zieman M, Fong SK, Benowitz NL. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997; 90: 88-92.
13. Corson SL, Bolognese R. Postpartum uterine atony treated with prostaglandins. Obstet Gynecol 1977; 129: 15.
14. Reuben Peyser, Kupferminc M. Management of severe postpartum hemorrhage intrauterine irrigation with prostaglandin E2, Serlin Maternity Hospital, Tel Aviv Israel. Am J Obstet Gynecol 1990; 162: 694-6.
15. Veber B, Gauthe M, Michel-Cherequi M. Severe hypertension during postpartum haemorrhage after i.v. administration of prostaglandin E2. Br J Anaesth 1992; 68: 623-4.
16. Kararli TT, Catalano T, Needham TE, Finnegan PM. Mechanism of misoprostol stabilization in Hydroxypropyl methylcellulose. Adv Exp Med Biol 1991; 302: 275-89.
17. Drife J. Management of primary postpartum haemorrhage (comment). Br J Obstet Gynaecol 1997; 104: 275-7.
18. Hogerzeil HV, Walker GJA, de Goeje MJ. Stability of injectable oxytocics in tropical climates. Geneva: World Health Organization, 1993.